NR3C2 and metabolic syndrome: Interestingly, our Adipo-MROE model presents a MetS-like phenotype with increased fat mass, insulin resistance, dyslipidemia and hyperglycemia, supporting a causal role of adipocyte-MR in the MetS [9], but the underlying mechanisms remained unclear, hence the present study.